Comera Life Sciences Holdings, Inc. (CMRA)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 9.97 Million USD | -54.88% |
| 2021 | 22.1 Million USD | 5510.69% |
| 2020 | 393.96 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 8.69 Million USD | 5.16% |
| 2023 Q1 | 8.26 Million USD | -17.15% |
| 2023 Q3 | 7.29 Million USD | -16.09% |
| 2022 Q3 | 8.36 Million USD | 5.58% |
| 2022 Q2 | 7.92 Million USD | -64.08% |
| 2022 Q1 | 22.05 Million USD | -0.23% |
| 2022 FY | 9.97 Million USD | -54.88% |
| 2022 Q4 | 9.97 Million USD | 19.24% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | 22.1 Million USD | 5510.69% |
| 2021 Q4 | 22.1 Million USD | 138.04% |
| 2021 Q3 | 9.28 Million USD | 0.0% |
| 2020 FY | 393.96 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| America Great Health | 4.82 Million USD | -106.721% |
| Ampio Pharmaceuticals, Inc. | 2.37 Million USD | -319.79% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | 74.377% |
| Biora Therapeutics, Inc. | 132.63 Million USD | 92.48% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -258.913% |
| Better Therapeutics, Inc. | 23.84 Million USD | 58.165% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -20.403% |
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | 62.131% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | 68.618% |
| Evelo Biosciences, Inc. | 69.43 Million USD | 85.635% |
| Evolutionary Genomics, Inc. | 7.94 Million USD | -25.531% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | 79.268% |
| Galera Therapeutics, Inc. | 157.32 Million USD | 93.66% |
| Innovation1 Biotech Inc. | 3.5 Million USD | -184.493% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | 53.15% |
| Molecular Templates, Inc. | 31.17 Million USD | 68.002% |
| Navidea Biopharmaceuticals, Inc. | 12.51 Million USD | 20.301% |
| NexImmune, Inc. | 5.08 Million USD | -96.179% |
| Orgenesis Inc. | 35.53 Million USD | 71.931% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | 39.594% |
| Point of Care Nano-Technology, Inc. | 266.41 Thousand USD | -3643.873% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -334.543% |
| Scopus BioPharma Inc. | 7.45 Million USD | -33.802% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 97.983% |
| Statera Biopharma, Inc. | 22.67 Million USD | 56.015% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | 8.611% |
| Trevena, Inc. | 48.26 Million USD | 79.333% |
| Vaxxinity, Inc. | 30.94 Million USD | 67.767% |
| Vaccinex, Inc. | 5.94 Million USD | -67.859% |
| Vicapsys Life Sciences, Inc. | 1.96 Million USD | -406.732% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | 74.007% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -261.18% |